Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the pastissues for the future

This publication has 19 references indexed in Scilit:

• Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial
  Journal of Hepatology, 2000
• Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis
  The Lancet, 1999
• Ursodeoxycholic Acid in Cholestasis: Potential Mechanisms of Action and Therapeutic Applications
  Hepatology, 1998
• A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg
  Alimentary Pharmacology & Therapeutics, 1998
• A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation.
  Journal of Clinical Investigation, 1998
• Ursodeoxycholic Acid Treatment in Patients with Primary Biliary Cirrhosis: A Swedish Multicentre, Double-Blind, Randomized Controlled Study
  Scandinavian Journal of Gastroenterology, 1997
• Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene
  Gastroenterology, 1996
• Ursodiol for the Long-Term Treatment of Primary Biliary Cirrhosis
  New England Journal of Medicine, 1994
• Ursodeoxycholic acid in the treatment of primary biliary cirrhosis
  Gastroenterology, 1994
• Serum bilirubin: a prognostic factor in primary biliary cirrhosis.
  Gut, 1979